HK2794A - 8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it - Google Patents

8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it Download PDF

Info

Publication number
HK2794A
HK2794A HK27/94A HK2794A HK2794A HK 2794 A HK2794 A HK 2794A HK 27/94 A HK27/94 A HK 27/94A HK 2794 A HK2794 A HK 2794A HK 2794 A HK2794 A HK 2794A
Authority
HK
Hong Kong
Prior art keywords
acylaminoergoline
preparation
pharmaceutical compositions
compositions containing
parkinson
Prior art date
Application number
HK27/94A
Other languages
English (en)
Inventor
Haefliger Walter
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK2794A publication Critical patent/HK2794A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
HK27/94A 1987-06-23 1994-01-13 8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it HK2794A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3720656 1987-06-23

Publications (1)

Publication Number Publication Date
HK2794A true HK2794A (en) 1994-01-21

Family

ID=6330087

Family Applications (1)

Application Number Title Priority Date Filing Date
HK27/94A HK2794A (en) 1987-06-23 1994-01-13 8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it

Country Status (28)

Country Link
US (1) US5075318A (da)
JP (1) JPH0670052B2 (da)
KR (1) KR970001527B1 (da)
AT (1) AT395242B (da)
AU (1) AU615657B2 (da)
BE (1) BE1004034A3 (da)
CA (1) CA1302404C (da)
CH (1) CH674646A5 (da)
CY (1) CY1752A (da)
DK (1) DK169335B1 (da)
ES (1) ES2010282A6 (da)
FI (1) FI88302C (da)
FR (1) FR2617166B1 (da)
GB (1) GB2206115B (da)
GR (1) GR1002318B (da)
HK (1) HK2794A (da)
HU (2) HU203097B (da)
IE (1) IE60550B1 (da)
IL (1) IL86820A (da)
IT (1) IT1219652B (da)
LU (1) LU87251A1 (da)
MY (1) MY103584A (da)
NL (1) NL8801597A (da)
NZ (1) NZ225112A (da)
PH (1) PH24690A (da)
PT (1) PT87781B (da)
SE (1) SE467925B (da)
ZA (1) ZA884505B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197569B (en) * 1984-01-12 1989-04-28 Sandoz Ag Process for producing 8alpha-acylaminoergoline derivatives and pharmaceuticals comprising such compounds
JP3630888B2 (ja) * 1996-10-31 2005-03-23 株式会社ニデック レンズ搬送装置と眼鏡レンズを搬送するための眼鏡レンズ用固定カップ及びレンズ搬送方法
KR20110071014A (ko) 2008-10-17 2011-06-27 위스콘신 얼럼나이 리서어치 화운데이션 생물학적으로 활성인 알파-베타 펩티드의 제조 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197569B (en) * 1984-01-12 1989-04-28 Sandoz Ag Process for producing 8alpha-acylaminoergoline derivatives and pharmaceuticals comprising such compounds
HU195810B (en) * 1984-12-24 1988-07-28 Sandoz Ag Process for preparing new 8alpha-acyl-amino-ergoline derivatives and pharmaceutical compositions containing such compounds

Also Published As

Publication number Publication date
GB2206115B (en) 1991-04-03
PH24690A (en) 1990-09-07
IL86820A (en) 1991-07-18
GR1002318B (el) 1996-05-13
DK340188D0 (da) 1988-06-21
DK340188A (da) 1988-12-24
AU1819488A (en) 1989-01-05
NZ225112A (en) 1991-03-26
JPH0670052B2 (ja) 1994-09-07
FI88302C (fi) 1993-04-26
IE881867L (en) 1988-12-23
AU615657B2 (en) 1991-10-10
GB8814615D0 (en) 1988-07-27
IE60550B1 (en) 1994-07-27
DK169335B1 (da) 1994-10-10
MY103584A (en) 1993-08-28
CA1302404C (en) 1992-06-02
SE8802323D0 (sv) 1988-06-21
NL8801597A (nl) 1989-01-16
IT8848097A0 (it) 1988-06-17
IL86820A0 (en) 1988-11-30
GR880100401A (el) 1989-03-08
AT395242B (de) 1992-10-27
BE1004034A3 (fr) 1992-09-15
CY1752A (en) 1994-06-03
US5075318A (en) 1991-12-24
ZA884505B (en) 1990-02-28
LU87251A1 (fr) 1989-03-08
HU203097B (en) 1991-05-28
ATA161788A (de) 1992-03-15
JPS6422876A (en) 1989-01-25
FI88302B (fi) 1993-01-15
GB2206115A (en) 1988-12-29
KR890000479A (ko) 1989-03-14
SE8802323L (sv) 1988-12-24
HUT50174A (en) 1989-12-28
CH674646A5 (da) 1990-06-29
SE467925B (sv) 1992-10-05
FI883008L (fi) 1988-12-24
FR2617166A1 (fr) 1988-12-30
KR970001527B1 (ko) 1997-02-11
HU211651A9 (en) 1995-12-28
FI883008A0 (fi) 1988-06-22
ES2010282A6 (es) 1989-11-01
PT87781A (pt) 1989-05-31
IT1219652B (it) 1990-05-24
PT87781B (pt) 1992-10-30
FR2617166B1 (fr) 1992-07-17

Similar Documents

Publication Publication Date Title
AU6905391A (en) Methods and compositions for the treatment of hodgkin's disease
CA2061917A1 (en) Pediatric effervescent dosage form
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
EP0331620A3 (en) Agent for the treatment of parkinson's disease
PH30439A (en) 3,4-Dihydro-2h-1,4-benz-oxazine derivatives and pharmaceutical compositions containing the same
JPS6426578A (en) 2,2-dimethylchroman-3-ol derivative, manufacture and drug composition
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
AU5980590A (en) 5-substituted 1,3,4-thiadizole derivatives, their preparation and their use as pesticides
AU8164287A (en) 3-(w-(3,5-di-t-butyl-4-hydroxyphenyl)- alkanoyl)pyrroles, their de-oxy analogs, and therapeutic uses thereof
CA2094275A1 (en) Methods and compositions for the treatment of cell proliferation disorders
NZ226516A (en) 2,2 dimethylchromene derivatives and pharmaceutical compositions
AU2101288A (en) Taliscanin and other aristolactams for treating neurological disorders, parkinson's disease, alzheimer disease and impotence
AU631334B2 (en) 2-substituted n,n'-ditrimethoxybenzoyl piperazines, and therapeutic compositions containing them
WO1989012380A3 (en) Therapeutic uses of 2',5'-oligoadenylate derivatives
NZ234369A (en) 6-(naphthalenylethyl)-4-hydroxy-pyran-2-one derivatives and the 3,5-dihydroxyheptanoates; pharmaceutical compositions
NZ227235A (en) Substituted 1,5-benzothiazepin-4-one derivatives and pharmaceutical compositions
HK2794A (en) 8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
IL95210A0 (en) 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
IL82294A0 (en) 1,3-dihydropyridine derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
AU6736096A (en) 1(hetero)aryl-4-(condensed thiazol-2-ylalkyl)-piperazine derivatives, their preparation and their use in the treatment of 5-ht1a-receptor mediated disorders
ZA924128B (en) New combination preparations for treatment of Parkinson's disease.
EP0302303A3 (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
ZA859695B (en) 2-(arylalkyloxymethyl)morpholine,preparation thereof and their application as drugs which are useful in the treatment of disorders of the central nervous system

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)